Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
78 hedge funds and large institutions have $266M invested in Vigil Neuroscience in 2025 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 18 closing their positions.
497% more capital invested
Capital invested by funds: $44.5M → $266M (+$221M)
156% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 18
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
56% more funds holding
Funds holding: 50 → 78 (+28)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
18% more ownership
Funds ownership: 53.63% → 71.63% (+18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$20.6M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$13.5M |
| 3 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
+$10.3M |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$5.33M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$4.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$7.14M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$6.97M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$3.07M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.86M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$2.81M |
VIGL Hedge Fund Activity: Q2 2025 in Review
78 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q2 2025, worth a combined $266M — up 497% from $44.5M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new VIGL positions and 18 closed out — a net gain of 28 holders — while 17 added to existing stakes and 9 trimmed.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $20.6M. The largest seller was BVF Inc, exiting entirely with an estimated $7.14M sold.
- 78 institutional investors held Vigil Neuroscience (VIGL) as of Q2 2025, up from 50 in Q1 2025.
- Funds reported $266M of Vigil Neuroscience stock for Q2 2025, up 497% quarter-over-quarter.
- 46 funds opened new Vigil Neuroscience positions in Q2 2025 and 18 closed out, a net change of +28 holders.
- The largest Vigil Neuroscience buyer in Q2 2025 was Beryl Capital Management, an estimated $20.6M added.
- The largest Vigil Neuroscience seller in Q2 2025 was BVF Inc, an estimated $7.14M sold.
Based on aggregated 13F filings for Q2 2025.